HCPCS Level II drug code
J0716 — Injection, centruroides immune f(ab)2, up to 120 milligrams
In short
J0716 is the HCPCS Level II code for injection, centruroides immune f(ab)2, up to 120 milligrams. The Medicare Part B payment limit is $5,449.649 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, centruroides immune f(ab)2, up to 120 milligrams
- Short descriptor
- Centruroides immune f(ab)
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2013
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. CMS note: Added October 2026. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
Find the NDC
Med-Code hasn’t mapped J0716 to specific products yet. Search the FDA NDC Directory for the drug named in the descriptor, and check the route and strength match the code.
J0716: common questions
- Is J0716 a CPT code?
- No. J0716 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What is the Medicare payment limit for J0716?
- $5,449.649 per up to 120mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.